A new Nature Communications study details how PD-1 (programmed cell death protein 1) balances T-cell responses during viral infection in the brain, helping control pathogens without driving excessive immune-mediated neurological damage. Led by Butic, Afanasiev, Spencer and colleagues, the work frames PD-1 as a regulator of immune coordination in a setting where inflammatory activity can itself become harmful.